Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedAug 12, 2026
DataAggregated Company Financials
Companies5
  • 7D-0.007%
  • 3M2.0%
  • 1Y-3.0%
  • YTD-6.7%

The Pharma industry has stayed flat over the last week. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to be flat in the coming years.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 13 Aug 2026DKK 1.4tDKK 361.5bDKK 121.4b11.7x11.9x4x
Sat, 11 Jul 2026DKK 1.5tDKK 359.9bDKK 126.9b11.7x12x4.2x
Mon, 08 Jun 2026DKK 1.4tDKK 359.9bDKK 126.9b11.9x10.7x3.8x
Wed, 06 May 2026DKK 1.4tDKK 340.3bDKK 106.9b13.2x12.8x4x
Fri, 03 Apr 2026DKK 1.1tDKK 340.0bDKK 106.8b12.7x10.6x3.3x
Sun, 01 Mar 2026DKK 1.1tDKK 340.0bDKK 106.8b12x10.7x3.4x
Tue, 27 Jan 2026DKK 1.9tDKK 345.8bDKK 108.6b17x17.1x5.4x
Thu, 25 Dec 2025DKK 1.6tDKK 345.8bDKK 108.6b14.2x14.4x4.5x
Sat, 22 Nov 2025DKK 1.4tDKK 345.8bDKK 108.6b13x13.3x4.2x
Mon, 20 Oct 2025DKK 1.6tDKK 341.3bDKK 115.5b13.7x14x4.7x
Wed, 17 Sep 2025DKK 1.7tDKK 341.3bDKK 115.5b14.4x14.6x4.9x
Fri, 15 Aug 2025DKK 1.5tDKK 341.2bDKK 115.4b13x13.2x4.5x
Sun, 13 Jul 2025DKK 2.0tDKK 331.8bDKK 108.8b18.6x18.6x6.1x
Tue, 10 Jun 2025DKK 2.3tDKK 331.8bDKK 108.8b20.8x20.7x6.8x
Thu, 08 May 2025DKK 2.0tDKK 330.9bDKK 108.7b19x18.9x6.2x
Sat, 05 Apr 2025DKK 2.0tDKK 317.9bDKK 104.9b19x18.9x6.2x
Mon, 03 Mar 2025DKK 2.9tDKK 317.9bDKK 104.9b28.3x28x9.2x
Wed, 29 Jan 2025DKK 2.8tDKK 297.4bDKK 98.1b28.6x28.9x9.5x
Fri, 27 Dec 2024DKK 2.8tDKK 297.4bDKK 98.2b29.1x28.8x9.5x
Sun, 24 Nov 2024DKK 3.4tDKK 297.4bDKK 98.2b35.2x34.8x11.5x
Tue, 22 Oct 2024DKK 3.7tDKK 283.9bDKK 93.2b39.8x39.3x12.9x
Thu, 19 Sep 2024DKK 4.0tDKK 283.9bDKK 93.2b43.5x42.9x14.1x
Sat, 17 Aug 2024DKK 4.2tDKK 283.1bDKK 92.9b45.3x44.7x14.7x
Mon, 15 Jul 2024DKK 4.4tDKK 269.3bDKK 92.2b48.7x47.9x16.4x
Wed, 12 Jun 2024DKK 4.4tDKK 269.3bDKK 92.2b48.8x48x16.4x
Fri, 10 May 2024DKK 4.0tDKK 269.1bDKK 92.1b44.1x43.4x14.9x
Sun, 07 Apr 2024DKK 3.9tDKK 257.0bDKK 86.4b46.3x45.5x15.3x
Tue, 05 Mar 2024DKK 4.0tDKK 257.0bDKK 86.4b46.8x46x15.5x
Thu, 01 Feb 2024DKK 3.5tDKK 238.8bDKK 78.2b45.8x44.9x14.7x
Sat, 30 Dec 2023DKK 3.2tDKK 238.8bDKK 78.2b41.3x40.5x13.3x
Mon, 27 Nov 2023DKK 3.3tDKK 238.8bDKK 78.2b42.5x41.6x13.6x
Wed, 25 Oct 2023DKK 3.1tDKK 225.4bDKK 70.1b45.3x44.3x13.8x
Fri, 22 Sep 2023DKK 2.9tDKK 225.4bDKK 70.1b42.7x41.8x13x
Sun, 20 Aug 2023DKK 2.9tDKK 224.8bDKK 69.9b41.7x40.8x12.7x
Price to Earnings Ratio

40.8x


Total Market Cap: DKK 2.9tTotal Earnings: DKK 69.9bTotal Revenue: DKK 224.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 28.3x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.9x which is lower than its 3-year average PE of 28.3x.
  • The 3-year average PS ratio of 9.3x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 20% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market0.16%
Healthcare0.63%
Pharma-0.0067%
Pharma-0.0067%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 299.501.8%
+DKK 23.0b		-8.1%PE11.4x
HLUN B H. LundbeckDKK 41.680.4%
+DKK 178.4m		17.1%PE11.1x
ALK B ALK-AbellóDKK 222.200.2%
+DKK 88.6m		21.4%PE38.5x

Latest News

NOVO B
DKK 299.50
Novo Nordisk
7D
1.8%
1Y
-8.1%
Narrative Update • Aug 10

NOVO: From Hypergrowth to Execution Mode

10.08.2026 New CEO Mike Doustdar: His strength lies less in building factories and more in building markets. From my perspective, the share price has been driven by a lot of exaggeration.
ALK B
DKK 222.20
ALK-Abelló
7D
0.2%
1Y
21.4%
HLUN B
DKK 41.68
H. Lundbeck
7D
0.4%
1Y
17.1%
STENO
DKK 0.93
Stenocare
7D
-0.9%
1Y
28.4%
PEG
DKK 0.088
Pharma Equity Group
7D
-5.2%
1Y
-28.3%